跳至主要内容
临床试验/NCT01223950
NCT01223950已完成不适用

Monitoring the Prevalence of E.R Admissions and Hospitalizations as a Result of Drug Related Problems (DRPs)

Hillel Yaffe Medical Center0 个研究点目标入组 12,350 人开始时间: 2010年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12,350

研究概览

简要总结

To research the prevalence and nature of DRP (Drug Related Problems) associated hospitalizations (hospitalizations due to problems\adverse effects of the medication treatment) .

Analyzing the main reasons for DRP associated E.R admissions\hospitalizations. identifying drug involved and percentage of DRP associated hospitalizations.

Monitoring the length of DRP associated hospitalizations. Evaluating LOS to hospitalized. Financial and other aspects will be measured.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Possible DRP based on the current literature, patient questionnaire and drug history, related laboratories test values, ICD-9 coding.

排除标准

  • DRP cannot be established or suspected based on the assessment of the patient's lab results, symptoms, drug treatment and patient's questioning as well as physician diagnosis

研究者

申办方类型
Other Gov

相似试验